RecruitingNot Applicable

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

United States5,000 participantsStarted 2015-01

Plain-language summary

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer Exclusion Criteria: * Patients with squamous cell carcinoma

What they're measuring

Overall improvement of patient outcomes in patients treated with endoscopic eradication therapy (EET).

Timeframe: 5 years

Trial details

NCT IDNCT02634645

SponsorUniversity of Colorado, Denver

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01

Contact for this trial

Sachin Wani, MD

720-848-2786 sachin.wani@ucdenver.edu

View on ClinicalTrials.gov More Barrett's Esophagus trials